Supporting Brain and Muscle Resilience in ALS
- Promoting Neurological and Muscular Resilience and Recovery
- Encouraging Optimal Motor Neuron Function and Development
- Helping Restore Healthy Neuromuscular Pathways
Reserve Your Spot for This Groundbreaking Presentation
Exclusive for Live Attendees
🎁 FREE BONUS: Attendees will be eligible for a complimentary consultation with a Perpetual Health Navigator to help create a personalized plan for supporting brain-body health and neurological function.
Join Dr. Dayan Goodenowe for a comprehensive discussion about the latest research on ALS, motor neuron function, and new scientific evidence of biochemical resilience and recovery mechanisms.
Are You Searching for Real Answers About ALS and Brain-Body Health?
Every 90 minutes in America, someone is diagnosed with ALS, and someone passes away from it. With 1 in 400 people developing ALS in their lifetime – understanding the biochemical mechanisms behind this devastating condition has never been more critical.
While the average survival after diagnosis is 2-5 years, more than half of ALS patients live beyond 3 years, 20% live five years or more, and 5% live 20 years or longer.
Why do some ALS patients experience better outcomes? The answer lies in understanding the biochemical mechanisms that influence motor neuron function – and that’s exactly what this presentation explores.
The First Step Forward is Understanding the Science
For too long, families affected by ALS have been told there are limited options beyond symptom management. But groundbreaking research reveals that ALS represents specific disruptions in motor neuron function and biochemical pathways that may respond to targeted support.
Studies show that 14% of ALS patients become long-term survivors, living five years or more. What’s remarkable is these individuals often cannot be identified by clinical features alone at diagnosis – suggesting that biochemical factors may play the crucial role.
Studies show that 14% of ALS patients become long-term survivors, living 5 years or more! For far too long, families affected by ALS have been told there are limited options beyond symptom management. But groundbreaking research reveals that ALS represents specific disruptions in motor neuron function and biochemical pathways that may respond to targeted support.
OCTOBER 22ND, 5PM PACIFIC
What Really Happens in ALS Development
ALS (Amyotrophic Lateral Sclerosis) represents more than muscle weakness. What makes ALS particularly challenging is that 90-95% of cases are sporadic—meaning they occur without any known family history or identifiable cause. This disease affects anyone, regardless of age, ethnicity, or background. Every day, 15 people in the United States are diagnosed with ALS.
According to leading research, ALS reflects specific disruptions in motor neuron function and neuromuscular communication. These neurological changes can affect:
- Motor neuron pathways that control voluntary muscle movement and function
- Mitochondrial processes that power cellular energy in both brain and muscle tissue
- Detoxification systems that protect against excitotoxic injury and oxidative stress
- Neuromuscular communication critical for maintaining muscle health and preventing wasting
The challenge isn’t that science doesn’t understand these mechanisms—it’s that traditional approaches often focus on managing symptoms rather than addressing the underlying biochemical factors that influence ALS progression.
When normal motor neuron and mitochondrial processes are disrupted, the brain-body connection struggles to maintain optimal communication and energy production. This can create a cascade of challenges affecting movement, muscle function, respiratory capacity, and overall quality of life.
Why This Research Matters—Even If ALS Hasn't Touched Your Life Yet
1 in 400 people will develop ALS. In a workplace of 200 people, statistically someone will be diagnosed. In a class of 400 students, one will face this disease.
With 90-95% of cases occurring sporadically – without family history – no one is protected. Annual care costs exceed $250,000 per patient, creating devastating burdens on families who never saw it coming.
This isn’t someone else’s problem. It’s a biochemical challenge that could affect anyone.
That’s why Dr. Goodenowe’s research into motor neuron health matters for everyone.
1 in 400 people will develop ALS. In a workplace of 200 people, statistically someone will be diagnosed. In a class of 400 students, one will face this disease.
That’s why Dr. Goodenowe’s research into motor neuron health matters for everyone.
Join Dr. Dayan Goodenowe on October 22nd as we explore:
- ALS and Brain-Body Health: How ALS affects motor neurons, muscle function, and the biochemical pathways that shape overall health and resilience
- Definable Mechanisms: The latest findings on mitochondria, dopaminergic systems, and mechanisms of brain resilience. Exploring the neurological and biochemical features of ALS, including excitotoxic injury to motor neurons and the mechanisms driving muscle wasting
- Restorative Science: How a biochemical lens is being applied to study energy systems, detoxification pathways, and neuronal protection in the context of ALS
- Stories of Resilience: Real experiences from individuals with ALS who have seen improvements in quality of life
Register Now:
This Conversation Changes Everything
Dr. Goodenowe presents the latest research on ALS that will challenge conventional understanding and provide cutting-edge scientific insights into motor neuron resilience and biochemical pathways.
Join hundreds of ALS families, caregivers, and healthcare professionals who are discovering new perspectives on neuromuscular health and biochemical support strategies.
OCTOBER 22ND, 5PM PACIFIC
INTRODUCING OUR SPEAKER
Dr. Dayan Goodenowe
World-Renowned Neuroscientist & Bestselling Author
Dr. Dayan Goodenowe is a world-renowned neuroscientist whose research into the biochemical mechanisms of disease started in 1990. His curiosity about the biochemistry of life remains as insatiable today as it was over three decades ago.
Dr. Goodenowe invented and developed advanced diagnostic and bioinformatic technologies, designed and manufactured novel biochemical precursors, and identified biochemical prodromes of numerous diseases including Alzheimer’s disease and dementia, Parkinson’s disease, multiple sclerosis, stroke, autism, amyotrophic lateral sclerosis (ALS), schizophrenia, bipolar disorder, depression, and multiple types of cancer.
As the founder of Prodrome Science and author of the bestselling book “Breaking Alzheimer’s,” Dr. Goodenowe’s research focuses on identifying and correcting the biochemical imbalances that affect brain function – long before symptoms become irreversible.
His current focus is to defeat the entropy of aging by creating strategic biochemical and biofunctional reserve capacity in advance of known disease risks, enabling the human body to maintain optimal physical and biological functions.
As the founder of Prodrome Science and author of the bestselling book "Breaking Alzheimer's," Dr. Goodenowe's research focuses on identifying and correcting the biochemical imbalances that affect brain function—long before symptoms become irreversible.
His current focus is to defeat the entropy of aging by creating strategic biochemical and biofunctional reserve capacity in advance of known disease risks, enabling the human body to maintain optimal physical and biological functions.
A New Approach to ALS Support
This isn’t about false promises or quick fixes. This presentation offers an evidence-based, scientifically-grounded approach to understanding ALS that goes beyond symptom management and explores pathways for genuine biochemical support and neurological optimization.
What You'll Discover:
- The biochemical factors that influence ALS progression and motor neuron health
- Why traditional approaches may be missing critical opportunities for support
- How supporting mitochondrial function can improve brain-body energy and resilience
- The role of detoxification pathways in protecting motor neurons from excitotoxic injury
- Practical pathways for supporting neuromuscular health in ALS across all stages
- Real stories of resilience from individuals with ALS experiencing improved quality of life
Live Webinar Details
Exclusive for Live Attendees
🎁 FREE BONUS: Attendees will be eligible for a complimentary consultation with a Perpetual Health Navigator to help create a personalized plan for supporting brain-body health and neurological function.
IT'S GOING TO BE A LECTURE YOU WON'T WANT TO MISS
Why Attend This Event?
- Live Q&A with Dr. Goodenowe on ALS research
- Exclusive research insights on motor neuron function and resilience
- Free consultation opportunity with Perpetual Health Navigator
- Access to cutting-edge biochemical research on ALS
- Stories of resilience from individuals with ALS
- Hybrid format - attend digitally or in person
Don't Miss This Groundbreaking Presentation
Whether you have ALS, are caring for someone with the condition, or work with individuals facing neurodegeneration, this presentation will provide you with direct, scientific insights and stories of resilience.
GROUNDBREAKING RESEARCH REVEALED
What People Are Saying About Dr. Goodenowe's Work
"Dr. Goodenowe's research has completely changed how we understand brain health. His scientific approach gives us hope and practical pathways forward."
"Finally, someone who explains the science behind neurodegeneration in a way that makes sense and offers real solutions for supporting neurological function."
"I am an Apollo Health Coach with a background in Bio/chem, and when I listened to Dr. Goodenowe's research, I was fascinated, intrigued and blown away. My heart beats for science, and his work has started to 'hang together' in ways that make real sense."
"Dr. Goodenowe's approach to brain biochemistry is revolutionary. He doesn't just talk about managing symptoms—he addresses the underlying mechanisms that can make a real difference in people's lives."
The Science of Hope Starts Here
Join hundreds of families and professionals who are discovering new pathways for supporting brain-body health in ALS and neurodegeneration.
Every day, 15 people in the U.S. are diagnosed with ALS—and every 90 minutes, someone passes away from the disease. With 1 in 400 people developing ALS in their lifetime, and global cases expected to increase by 69% by 2040, research into biochemical mechanisms has never been more urgent.
OCTOBER 22nd, 5PM PACIFIC
This webinar is presented by Perpetual Health. Dr. Goodenowe’s research-based insights are grounded in peer-reviewed science and clinical experience.